CompaniesHotSpot Therapeutics
HotSpot Therapeutics logo

HotSpot Therapeutics

active
Boston, MA, United States
Founded 2017
Website
About

Small Molecules designed for Distinct Protein Domains

Areas of Focus

Categories

Small Molecule PharmaceuticalBoston & New England
Team (2)
Investors(alphabetical order)
HotSpot Therapeutics
team_member
Management
Management
Co-Founder and Chief Executive Officer
HotSpot Therapeutics
executivefounder
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

77

By Phase

PHASE1/PHASE2: 1

By Status

ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
NCT05662397
Hover over trial bars to see details

Recent Trials

NCT05662397Lead Sponsor
A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
PHASE1/PHASE2Active, not recruiting
77 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2026
Locations (1)
Headquarters
Boston, MA, United States
Map

Loading map...